Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2015 Aug;46(2):495-502.
doi: 10.1183/09031936.00217114. Epub 2015 Apr 2.

Mortality among patients with pleural effusion undergoing thoracentesis

Erin M DeBiasi  1 , Margaret A Pisani  1 , Terrence E Murphy  2 , Katy Araujo  2 , Anna Kookoolis  1 , A Christine Argento  3 , Jonathan Puchalski  4
Affiliations
Observational Study

Mortality among patients with pleural effusion undergoing thoracentesis

Erin M DeBiasi et al. Eur Respir J. 2015 Aug.

Abstract

Of the 1.5 million people diagnosed with pleural effusion in the USA annually, ~178 000 undergo thoracentesis. While it is known that malignant pleural effusion portends a poor prognosis, mortality of patients with nonmalignant effusions has not been well studied.This prospective cohort study evaluated 308 patients undergoing thoracentesis. Chart review was performed to obtain baseline characteristics. The aetiology of the effusions was determined using standardised criteria. Mortality was determined at 30 days and 1 year.247 unilateral and 61 bilateral thoracenteses were performed. Malignant effusion had the highest 30-day (37%) and 1-year (77%) mortality. There was substantial patient 30-day and 1-year mortality with effusions due to multiple benign aetiologies (29% and 55%), congestive heart failure (22% and 53%), and renal failure (14% and 57%, respectively). Patients with bilateral, relative to unilateral, pleural effusion were associated with higher risk of death at 30 days and 1 year (17% versus 47% (hazard ratio (HR) 2.58, 95% CI 1.44-4.63) and 36% versus 69% (HR 2.32, 95% CI 1.55-3.48), respectively).Patients undergoing thoracentesis for pleural effusion have high short- and long-term mortality. Patients with malignant effusion had the highest mortality followed by multiple benign aetiologies, congestive heart failure and renal failure. Bilateral pleural effusion is distinctly associated with high mortality.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pleural Effusions and Mortality
Figure 2
Figure 2
Percentage of Mortality within Etiologic Category
Figure 3
Figure 3
See this image and copyright information in PMC

References

    1. Light RW. Pleural Diseases. Lippincott Williams & Wilkins; 2007.
    1. Light RW. Pleural Effusions. Medical Clinics of North America. 2011;95(6):1055–70. - PubMed
    1. Puchalski JT, Argento AC, Murphy TE, Araujo KL, Oliva IB, Rubinowitz AN, et al. Etiologies of bilateral pleural effusions. Respir Med. 2013;107(2):284–91. - PMC - PubMed
    1. Kalomenidis I, Rodriguez M, Barnette R, Gupta R, Hawthorne M, Parkes KB, et al. Patient with bilateral pleural effusion: are the findings the same in each fluid? Chest. 2003;124(1):167–76. - PubMed
    1. Light RW, Macgregor MI, Luchsinger PC, Ball WC., Jr Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77(4):507–13. - PubMed

Publication types

LinkOut - more resources